LakeShore Biopharma Co. Ltd (LSB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    LakeShore Biopharma Co. L...

    NASDAQ: LSB · Real-Time Price · USD
    0.83
    -0.05 (-5.41%)
    At close: Sep 12, 2025, 3:59 PM
    0.80
    -3.43%
    After-hours: Sep 12, 2025, 06:57 PM EDT

    LakeShore Biopharma Ltd Income Statement

    Financials in CNY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 614.96M 573.42M 687.2M 502.95M 257.02M
    Cost of Revenue
    		 107.77M 117.69M 153.36M 117.07M 59.66M
    Gross Profit
    		 507.19M 455.73M 533.84M 385.88M 197.36M
    Operating Income
    		 -86.29M -445.83M -139.38M -549.18K -125.85M
    Interest Income
    		 n/a n/a n/a n/a n/a
    Pretax Income
    		 -100.93M -455.19M -144.35M -545.73K -174.37M
    Net Income
    		 -99.98M -433.46M -145.48M -545.73K -191.83M
    Selling & General & Admin
    		 390.73M 428.09M 333.32M 272.77M 208.33M
    Research & Development
    		 146.37M 302.8M 318.7M 211.22M 94.39M
    Other Expenses
    		 56.38M 170.67M -199.45K -2.41M -22.36M
    Operating Expenses
    		 593.48M 901.56M 647.15M 549.18K 319.68M
    Interest Expense
    		 15.74M 44.34M 30.86M 2.72M 29.69M
    Selling & Marketing Expenses
    		 254.74M 280.45M 251.56M 165.72M 69.44M
    Cost & Expenses
    		 701.25M 1.02B 800.51M 549.18K 379.33M
    Income Tax Expense
    		 -946.87K -21.73M 1.13M 4.94M 17.45M
    Shares Outstanding (Basic)
    		 106.92M 106.92M 77.42M 29.5M 28.75M
    Shares Outstanding (Diluted)
    		 106.92M 106.92M 77.42M 29.5M 28.75M
    EPS (Basic)
    		 -0.94 -4.05 -1.88 -0.02 -6.67
    EPS (Diluted)
    		 -0.94 -4.05 -1.88 -0.02 -6.67
    EBITDA
    		 -48.54M -368.66M -76.8M -67.2M -116.78M
    EBIT
    		 -85.19M -410.85M -113.49M -98.35M -144.68M
    Depreciation & Amortization
    		 36.65M 42.19M 36.69M 31.15M 27.91M

    Add to Watchlist